Chronic Lyme Disease and Long-Term Lyme: Both Sides, Explained

Quick answer

Yes, long-term symptoms after Lyme disease are real. CDC says most people recover with 2 to 4 weeks of antibiotics, but some have fatigue, pain or trouble thinking for months or longer. What experts disagree on is the cause and the treatment: CDC and IDSA call this PTLDS and advise against more antibiotics, while ILADS and many patients believe some cases involve ongoing infection.

This page lays out both sides fairly, with sources, to help you talk with your own clinician. Beat Lyme does not take sides in the debate, but we do take your side: your symptoms deserve to be taken seriously.

The words people use, and what they mean

Much of the confusion starts with vocabulary. Here is how the four common labels differ:

In short: late Lyme is an untreated infection, PTLDS describes symptoms after treatment, and chronic Lyme is a broader term that can include both. For a deeper look at the CDC term, see post-treatment Lyme disease syndrome. For infections found late, see untreated Lyme disease years later.

What CDC and IDSA say

CDC and the 2020 guideline from the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN) and American College of Rheumatology (ACR) represent the mainstream view. CDC says its treatment regimens are consistent with this guideline. Their main points:

• The symptoms are real. CDC cites studies that found fatigue, aches or thinking problems were 5 to 10% more common 6 months after treatment in people who had Lyme than in people who had not.
• The cause is unknown. CDC notes that similar long-lasting symptoms have been reported after other infections, including COVID-19.
• Check for other causes. CDC lists other infections, medicines, depression, diabetes and cancer as things that can cause similar symptoms.
• More antibiotics are not recommended for nonspecific symptoms without objective signs of active disease. The IDSA guideline rates this a strong recommendation based on moderate-quality evidence.
• People usually improve over time. CDC says patients generally get better without more antibiotics, though full recovery can take many months.
• Treat the symptoms that matter most. CDC suggests working with your provider on the problems that most affect daily life. It says strategies developed for ME/CFS may help with fatigue, post-exertional malaise, sleep, pain, memory, mood and dizziness.

NIAID, part of the National Institutes of Health, takes the same position. It says more antibiotics are not helpful and can be dangerous for people with PTLDS who have no evidence of active infection.

What ILADS and patient advocates say

The International Lyme and Associated Diseases Society (ILADS) is a group of clinicians whose 2014 guideline takes a different view. It is followed by some clinicians. Its main points:

• Patients with ongoing symptoms and signs should first be checked for other possible causes.
• If a chronic Lyme infection is judged to be a possible cause and the person’s quality of life is impaired, ILADS recommends antibiotic retreatment.
• Because ILADS found that trials using 20 or fewer days of treatment had low success rates, it recommends longer first courses for the rash (4 to 6 weeks) and reassessing patients at the end of treatment.
• ILADS openly says its own review rated the available evidence as very low quality. Its recommendations therefore lean more on clinician judgment than on trial results.

Patient advocacy groups such as LymeDisease.org add another perspective. They argue that many people are diagnosed late or misdiagnosed, that standard tests can miss infections, and that the bacteria may persist in some people after treatment. They also stress how heavily these illnesses weigh on daily life, a point the government-funded trials themselves documented.

What the research shows

Four placebo-controlled trials funded by the National Institutes of Health tested longer antibiotic treatment in people with persistent symptoms after Lyme. A large European trial followed. Here is what they found:

Two other things are worth knowing. First, NIAID notes that the placebo effect in these studies was reported as high as 40%, which may explain why some people feel better on any treatment. Second, the trials have been read in different ways. A 2013 review by several of the original investigators noted that two other groups had reanalyzed the trials and judged that longer antibiotic courses are likely helpful. The review authors disagreed. They concluded that retreatment gives little if any benefit and carries significant risk.

Research on whether the bacteria can persist

This is an active and unsettled area. NIAID reports that researchers found remnants of Lyme bacteria in mice after antibiotic treatment, and that intact bacteria persisted in some treated monkeys, though they could not be grown in the lab and it is not known whether they were infectious. A small human study that used lab-raised ticks to look for bacteria in people with ongoing symptoms was described by NIAID as preliminary. These findings are early. They do not yet show that persistence causes symptoms in people, or that any treatment fixes it.

Where research is happening now

• Johns Hopkins Lyme Disease Research Center studies three possible explanations: lingering microbes, an immune system that stays switched on, and changes in how the brain and nerves process signals. It says the cause is likely more than one thing. It also lists a small pilot study on how well people with post-treatment Lyme tolerate a tetracycline antibiotic.
• Columbia University’s Lyme and Tick-Borne Diseases Research Center focuses on better tests, better treatments and understanding why symptoms persist. Its current studies include vagus nerve stimulation and a brain-stimulation approach for brain fog, plus a patient registry.
• CDC says it is studying how often prolonged symptoms happen and their impact, and building a shared research agenda for illnesses that follow infections.

For more on studies you may be able to join, see Lyme disease research.

What patients report

Registry members are not a random sample, so these are not population statistics, but they show what many people with long-term Lyme experience. The figures below are patient-reported data from LymeDisease.org’s MyLymeData registry, as summarized in LymeDisease.org’s report Diagnosing Lyme in Time:

• In a 2025 MyLymeData study, 74% of chronic patients said they were first misdiagnosed. The most common earlier diagnoses were a psychiatric disorder (52%), fibromyalgia (43%) and chronic fatigue syndrome (42%).
• In the same 2025 study, only 45% of chronic patients recalled a rash, and just 10% were diagnosed in the first month.
• Chronic patients were four times as likely as acute patients to report being disabled from work (28% vs 6%) in the 2025 study, and far more likely to rate their quality of life as fair or poor (74% vs 36%).
• In a 2023 MyLymeData study, women made up 77% of chronic patients but 42% of acute patients.
• LymeDisease.org also reports that about half of chronic patients in its surveys saw seven or more clinicians before being diagnosed.

Whatever the cause of long-term symptoms turns out to be, early and accurate diagnosis is something CDC and patient groups both emphasize.

How long to treat: where the guidelines split

Much of the debate comes down to treatment length. Here is how the two guidelines compare. Your provider will decide what fits you; this site does not give doses.

See the Lyme disease treatment guide for how standard treatment works, and our IDSA vs ILADS comparison for the full picture.

Risks of long-term antibiotics and unproven treatments

When nothing seems to work, it is natural to want to try anything. Knowing the risks helps you weigh options with a clinician you trust.

• Long-term antibiotics. CDC says long-term antibiotic use has been linked to serious complications, including sepsis and colitis. In the trials above, serious side effects affected a meaningful share of people on long IV treatment.
• IV lines. A 2017 CDC report (MMWR) described five patients diagnosed with chronic Lyme disease who developed serious bacterial infections during treatment, including bloodstream infections from IV catheters, septic shock, a spine infection and C. difficile colitis. One person died of septic shock.
• Unproven therapies. The same report listed treatments such as hydrogen peroxide infusions, immunoglobulin therapy, colloidal silver, electromagnetic treatments and stem cell transplants. CDC’s authors wrote that treatments for chronic Lyme disease lack proof of effectiveness and can cause serious complications.

Before any treatment, ask: What is the evidence it works? What are the risks? How will we know if it is helping, and when will we stop?

Finding support and a second opinion

You deserve care that takes you seriously, whichever approach you and your clinician choose. Some practical steps:

1. Keep a simple symptom log. Note your worst symptoms, how they affect work, sleep and daily tasks, and what makes them better or worse. Our doctor visit guide has a checklist.
2. Ask for a full workup. CDC recommends looking at all possible causes. Ask about co-infections from the same tick bite (see co-infections) and conditions that overlap with Lyme (see Lyme and other conditions).
3. Use shared decision-making. CDC suggests telling your provider how you feel, asking questions, asking for clarification and setting goals you can reach together.
4. Ask about specialists. CDC suggests considering a rheumatologist for joint swelling that doesn’t respond to treatment. An infectious disease specialist can review your diagnosis and treatment history.
5. Get a second opinion if you feel stuck. Bring your test results, treatment history and symptom log.
6. Find your people. Support groups can ease isolation and share practical tips. See Lyme disease support groups.

Long-term symptoms can affect mood, sleep and energy. See Lyme disease and mental health, Lyme disease fatigue and recovering from Lyme disease. If work is affected, our disability guide may help.

Explore long-term Lyme

This page is part of step 5 of our How to beat Lyme guide. Beating Lyme is something we work on together.

Keep reading: public figures who have shared their Lyme stories, Lyme symptoms in women and the latest Lyme news.

Frequently asked questions